Net sales rose 6% year-over-year in H1 2026, while comparable EBITA remained stable and orders received declined 14%. The Severn acquisition strengthens the Process Performance Solutions segment, and cost savings from operating model renewal supported profitability. Guidance for 2026 is unchanged.O…
Net sales rose 6% year-over-year in H1 2026, while comparable EBITA remained stable and orders received declined 14%. The Severn acquisition strengthens the Process Performance Solutions segment, and cost savings from operating model renewal supported profitability. Guidance for 2026 is unchanged.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.